Aestura logo

Aestura

Last updated April 13, 2026
12
Innovation Areas

Green Tea Peptide Therapeutics: AesturaRecent Research Landscape

Green tea peptides exhibit low bioavailability and rapid metabolic clearance, requiring specialized formulation to target muscle recovery and metabolic health.

What technical problems is Aestura addressing in Green Tea Peptide Therapeutics?

Systemic Burnout and Immunosenescence

(17)evidences

Ginseng berry polysaccharides and specific ginsenosides are required to mitigate macrophage inactivity and cytokine deficiency during physical exhaustion.

Sarcopenia and Metabolic Fatigue

(22)evidences

Muscle tissue degradation and metabolic fatigue require specific fermented green tea peptide fractions to prevent protein loss and cellular exhaustion.

Lipogenesis and Hepatic Dysregulation

(17)evidences

Excessive fat accumulation and liver oxidative stress occur when epigallocatechin gallate and isoquercetin ratios are not optimized for blood sugar regulation.